Pharmacokinetics and Pharmacodynamics

Smith HS.
Opioid Metabolism
Mayo Clin Proc. 2009;84(7):613-24.
http://www.mayoclinicproceedings.org/article/S0025-6196(11)60750-7/fulltext
http://download.journals.elsevierhealth.com/pdfs/journals/0025-6196/PIIS0025619611607507.pdf

Toombs JD.
Oral Methadone Dosing for Chronic Pain: A Practitioner’s Guide
Pain Treatment Topics. March 12, 2008.
Available at: http://pain-topics.org/pdf/OralMethadoneDosing.pdf

Webster, Lynn R.
Butrans® (buprenorphine) Transdermal System
http://www.painmedicinenews.com/download/SR1134_WM.pdf

Krantz MJ, Martin J, Stimmel B, Mehta D, Haigney MC.
QTc Interval Screening in Methadone Treatment
Ann Intern Med. 2009;150(6):387-95.
http://www.annals.org/content/150/6/387.full

Webster L, St. Marie B, McCarberg B, Passik SD, Panchal SJ, Voth E.
Current status and evolving role of abuse-deterrent opioids in managing patients with chronic pain.
J Opioid Manage. 2011:7(3):235-45.
http://www.ncbi.nlm.nih.gov/pubmed/21823554